Benjamin Louis Schlechter, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokine CCL5 | 1 | 2024 | 214 | 0.880 |
Why?
|
| Carcinoma, Pancreatic Ductal | 7 | 2024 | 1728 | 0.830 |
Why?
|
| Receptors, CCR5 | 1 | 2024 | 486 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 5369 | 0.640 |
Why?
|
| Colorectal Neoplasms | 4 | 2024 | 6935 | 0.550 |
Why?
|
| Rectal Neoplasms | 2 | 2022 | 1157 | 0.530 |
Why?
|
| Teaching Rounds | 2 | 2019 | 275 | 0.520 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 2538 | 0.470 |
Why?
|
| Neoplasm Metastasis | 4 | 2024 | 4915 | 0.250 |
Why?
|
| DNA Fingerprinting | 1 | 2004 | 114 | 0.230 |
Why?
|
| Adenocarcinoma | 4 | 2023 | 6346 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 11742 | 0.190 |
Why?
|
| Appendiceal Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
|
| Giant Cells | 1 | 2021 | 188 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 2827 | 0.180 |
Why?
|
| Anus Neoplasms | 1 | 2024 | 329 | 0.170 |
Why?
|
| Loss of Heterozygosity | 4 | 2008 | 662 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 999 | 0.160 |
Why?
|
| Quercetin | 1 | 2019 | 97 | 0.160 |
Why?
|
| Neutropenia | 1 | 2023 | 885 | 0.150 |
Why?
|
| Israel | 1 | 2019 | 726 | 0.140 |
Why?
|
| Fluorouracil | 1 | 2022 | 1642 | 0.140 |
Why?
|
| Osteoclasts | 1 | 2021 | 711 | 0.140 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2019 | 208 | 0.140 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2022 | 3514 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2023 | 711 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9280 | 0.140 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 1866 | 0.130 |
Why?
|
| Neoplasms | 3 | 2020 | 22173 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2024 | 953 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 954 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 1052 | 0.130 |
Why?
|
| Referral and Consultation | 2 | 2019 | 3600 | 0.130 |
Why?
|
| Embolism | 1 | 2019 | 399 | 0.130 |
Why?
|
| International Council of Nurses | 1 | 1994 | 3 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 2020 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2019 | 339 | 0.120 |
Why?
|
| Palliative Care | 2 | 2019 | 3598 | 0.110 |
Why?
|
| International Agencies | 1 | 1994 | 243 | 0.110 |
Why?
|
| Neoplasm Staging | 4 | 2022 | 11121 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 1459 | 0.100 |
Why?
|
| Humans | 32 | 2024 | 761572 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2021 | 2242 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 1613 | 0.100 |
Why?
|
| Paclitaxel | 3 | 2024 | 1732 | 0.100 |
Why?
|
| Hernia, Inguinal | 1 | 1994 | 220 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 1994 | 311 | 0.090 |
Why?
|
| Anastomosis, Surgical | 1 | 1994 | 983 | 0.090 |
Why?
|
| Temporal Muscle | 1 | 1990 | 36 | 0.090 |
Why?
|
| Meningocele | 1 | 1990 | 47 | 0.090 |
Why?
|
| Meningitis, Aseptic | 1 | 1990 | 59 | 0.090 |
Why?
|
| Femoral Artery | 1 | 1994 | 826 | 0.090 |
Why?
|
| Deoxycytidine | 2 | 2024 | 877 | 0.080 |
Why?
|
| Suture Techniques | 1 | 1994 | 769 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2008 | 43 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 4026 | 0.080 |
Why?
|
| DNA, Neoplasm | 2 | 2023 | 1745 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9177 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 21017 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 2115 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 2024 | 784 | 0.060 |
Why?
|
| Middle Aged | 13 | 2024 | 220920 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4431 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 1062 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2008 | 1085 | 0.050 |
Why?
|
| Female | 16 | 2024 | 392686 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4319 | 0.050 |
Why?
|
| Mucin 5AC | 1 | 2023 | 96 | 0.050 |
Why?
|
| Thrombosis | 1 | 2016 | 2942 | 0.050 |
Why?
|
| Laparoscopy | 1 | 1994 | 2036 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 1 | 2024 | 883 | 0.050 |
Why?
|
| Aged | 10 | 2024 | 169310 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3877 | 0.050 |
Why?
|
| Microsatellite Instability | 1 | 2024 | 716 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2023 | 629 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2024 | 1089 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2005 | 1158 | 0.040 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2020 | 344 | 0.040 |
Why?
|
| Postoperative Complications | 4 | 2021 | 15633 | 0.040 |
Why?
|
| Enoxaparin | 1 | 2020 | 391 | 0.040 |
Why?
|
| Surgical Flaps | 2 | 1997 | 1671 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 1858 | 0.040 |
Why?
|
| Varicose Ulcer | 1 | 1997 | 55 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80646 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1844 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1745 | 0.030 |
Why?
|
| Organoids | 1 | 2022 | 743 | 0.030 |
Why?
|
| Mammaplasty | 1 | 2005 | 1239 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 931 | 0.030 |
Why?
|
| Back | 1 | 1995 | 64 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13642 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2023 | 41493 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2425 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 58986 | 0.030 |
Why?
|
| Male | 9 | 2024 | 360842 | 0.030 |
Why?
|
| Laparoscopes | 1 | 1994 | 37 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 1994 | 135 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2057 | 0.030 |
Why?
|
| Fibrin | 1 | 2016 | 507 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2024 | 2557 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 6534 | 0.030 |
Why?
|
| Alleles | 1 | 2004 | 6864 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Peritoneum | 1 | 1994 | 225 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1994 | 218 | 0.030 |
Why?
|
| Carcinoma, Lobular | 2 | 2008 | 481 | 0.030 |
Why?
|
| Physician's Role | 1 | 2019 | 917 | 0.020 |
Why?
|
| Linear Models | 1 | 2022 | 5872 | 0.020 |
Why?
|
| Human Rights | 1 | 1994 | 309 | 0.020 |
Why?
|
| Dogs | 2 | 1994 | 3839 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6344 | 0.020 |
Why?
|
| Advance Care Planning | 1 | 2019 | 699 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2023 | 4513 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1674 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1994 | 911 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4580 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7213 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2004 | 22176 | 0.020 |
Why?
|
| Mutation | 2 | 2024 | 30054 | 0.020 |
Why?
|
| Microsurgery | 1 | 1994 | 795 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1990 | 307 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 12059 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2024 | 54426 | 0.020 |
Why?
|
| International Cooperation | 1 | 1994 | 1422 | 0.020 |
Why?
|
| Gastrostomy | 1 | 1991 | 323 | 0.020 |
Why?
|
| Animals | 5 | 2024 | 168467 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
| Rabbits | 1 | 1994 | 4772 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15266 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2019 | 2521 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 1990 | 544 | 0.020 |
Why?
|
| Teratoma | 1 | 1990 | 404 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 1213 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5672 | 0.020 |
Why?
|
| Adult | 5 | 2024 | 221203 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10766 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81533 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 20099 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9420 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2016 | 2479 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2005 | 77 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2024 | 64684 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 22172 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2020 | 4812 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 2751 | 0.010 |
Why?
|
| Abdominal Muscles | 2 | 1997 | 169 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3548 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15843 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1990 | 1948 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.010 |
Why?
|
| Epithelium | 1 | 2005 | 1603 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 23996 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2787 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 4243 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39107 | 0.010 |
Why?
|
| Venous Insufficiency | 1 | 1997 | 108 | 0.010 |
Why?
|
| Back Injuries | 1 | 1995 | 41 | 0.010 |
Why?
|
| Wound Healing | 2 | 1997 | 2805 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 74213 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6075 | 0.010 |
Why?
|
| Premedication | 1 | 1995 | 246 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2005 | 9646 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1997 | 748 | 0.010 |
Why?
|
| Veins | 1 | 1997 | 768 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 39970 | 0.010 |
Why?
|
| Debridement | 1 | 1995 | 493 | 0.010 |
Why?
|
| Connective Tissue Diseases | 1 | 1995 | 285 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13255 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 8633 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1991 | 211 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 18398 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1995 | 1189 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 14607 | 0.000 |
Why?
|
| Reoperation | 1 | 1997 | 4303 | 0.000 |
Why?
|
| Stomach | 1 | 1991 | 696 | 0.000 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1995 | 1159 | 0.000 |
Why?
|
| Catheterization | 1 | 1991 | 1428 | 0.000 |
Why?
|
| Adolescent | 1 | 1990 | 88324 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1995 | 2491 | 0.000 |
Why?
|
| Models, Biological | 1 | 1991 | 9469 | 0.000 |
Why?
|